Ketamine’s promise as an antidepressant is being undermined by its lack of profit

Olivia Goldhill
·4-min read
Ketamine’s promise as an antidepressant is being undermined by its lack of profit
Ketamine’s promise as an antidepressant is being undermined by its lack of profit

The FDA approved a drug, esketamine, that can help with depression. But some psychiatrists question why ketamine, its cheaper cousin, isn't being similarly developed.